The impact of elexacaftor/tezacaftor/ivacaftor on body composition in a small cohort of youth with cystic fibrosis
Pediatric Pulmonology · 2023
DOI: 10.1002/ppul.26388 ↗Kurz gefasst
Leserbrief in der Zeitschrift Pediatric Pulmonology, 2023. Verfasst von Andrea Granados und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Nicklaus Children's Hospital, Miami, Florida, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis, Insulin Resistance. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: NIDDK NIH HHS, Cystic Fibrosis Foundation.
Abstract (Originalsprache)
Background
The effects of elexacaftor‐tezacaftor‐ivacaftor (ETI) on body composition in people with CF (pwCF) are unknown.
Methods
Dual‐energy X‐ray absorptiometry fat‐free mass and fat mass adjusted for height (FMI) as well as oral glucose tolerance test derived measures of insulin secretion and sensitivity were compared before and after ETI initiation in eight pwCF.
Results
Patients median age: 22 years interquartile range (IQR: 16–28), 87.5% male, median time on ETI:11 months. Weight z ‐score increased from −0.52 to 0.18 ( p = 0.014); FMI increased from 4.12 to 6.29 ( p = 0.014). Insulin secretion (C pep iAUC/Gluc iAUC) increased from 8.71 to 14.21 ( p = 0.021), insulin resistance (HOMA2 IR) increased from 0.73 to 1.25 ( p = 0.014) and insulin sensitivity decreased (Matsuda) 8.88 to 5.58 ( p = 0.036).
Conclusions
ETI resulted in increased weight and fat mass. BMI and muscle mass did not change. Both insulin secretion and insulin resistance increased. Longer‐term metabolic consequences of ETI need further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Nicklaus Children's Hospital, Miami, Florida, USA.
- Department of Pediatrics, Children's Hospital Colorado, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
- Division of Diabetes, Department of Medicine, Endocrinology and Metabolism, University of Minnesota, Minneapolis, Minnesota, USA.
- Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri, USA.
- Department of Pediatrics, University of Iowa Stead Family Children's hospital, Iowa City, Iowa, USA.
- Fraternal Order of Eagles Diabetes Research Center, University of Iowa, Iowa City, Iowa, USA.
ORCID-Profile: Andrea Granados, Amir Moheet, Katie Larson Ode
Förderung
- NIDDK NIH HHS
- Cystic Fibrosis Foundation
Zitieren
APA
Granados, A., Chan, C. L., Moheet, A., Vigers, T., Arbeláez, A. M., & Larson Ode, K. (2023). The impact of elexacaftor/tezacaftor/ivacaftor on body composition in a small cohort of youth with cystic fibrosis. Pediatric Pulmonology. https://doi.org/10.1002/ppul.26388
Vancouver
Granados A, Chan CL, Moheet A, Vigers T, Arbeláez AM, Larson Ode K. The impact of elexacaftor/tezacaftor/ivacaftor on body composition in a small cohort of youth with cystic fibrosis. Pediatric Pulmonology. 2023. doi:10.1002/ppul.26388
BibTeX
@article{Granados2023,
author = {Granados, Andrea and Chan, Christine L and Moheet, Amir and Vigers, Timothy and Arbeláez, Ana María and Larson Ode, Katie},
title = {The impact of elexacaftor/tezacaftor/ivacaftor on body composition in a small cohort of youth with cystic fibrosis},
journal = {Pediatric Pulmonology},
year = {2023},
doi = {10.1002/ppul.26388}
}
EUVIMED